The optimization of cell therapy by combinational application with apicidin-treated mesenchymal stem cells after myocardial infarction

Although mesenchymal stem cells (MSC) have been shown to be safe in preclinical studies of cardiovascular disease, multiple meta-analyses have debated whether functional improvement is significant or not. The cardiac differentiation from MSC is achievable using cardiogenic factors, however, the high...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Dong Im, Kang, Wan Seok, Hong, Moon Hwa, Kang, Hye Jin, Kim, Mi Ra, Kim, Min Chul, Kim, Yong Sook, Ahn, Youngkeun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546480/
https://www.ncbi.nlm.nih.gov/pubmed/28498815
http://dx.doi.org/10.18632/oncotarget.17471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546480/
https://www.ncbi.nlm.nih.gov/pubmed/28498815
http://dx.doi.org/10.18632/oncotarget.17471

Ejemplares similares